Skip to main navigation

Menu

About Us
- Our Team
  - Our Chief Innovator
- Our Network
Technology
Pipeline
MEDIA
Investors
Careers
Get In Touch

News Releases

Year

Rani Therapeutics Initiates Phase 1 Study of RT-111 (RaniPill® Containing Ustekinumab Biosimilar, CT-P43)

Sep 18, 2023

Rani Therapeutics Announces Successful Drug Delivery of High-Capacity Pill in Preclinical Studies

Sep 07, 2023

Rani Therapeutics to Participate in September Investor Conferences

Sep 06, 2023

Rani Therapeutics Reports Second Quarter 2023 Financial Results; Provides Corporate Update

Aug 11, 2023

Rani Therapeutics to Participate in August Investor Conferences

Aug 04, 2023

Rani Therapeutics’ Presentation On Oral Delivery of PTH for Osteoporosis Named Presidential Poster Competition Winner at ENDO 2023 Annual Conference

Jun 21, 2023

Rani Therapeutics Announces Acceptance of Late-Breaking Abstract of Oral Delivery of GLP-1 Agonist at the American Diabetes Association Annual Conference

Jun 08, 2023

Rani Therapeutics and Celltrion Expand Partnership to Include Adalimumab Biosimilar for RT-105

Jun 05, 2023

Rani Therapeutics to Present at the Jefferies Healthcare Conference

Jun 01, 2023

Rani Therapeutics Announces Acceptance of Three Abstracts for Presentation at ENDO 2023 Annual Conference

May 31, 2023

Rani Therapeutics Appoints Kate McKinley as Chief Business Officer

May 24, 2023

Rani Therapeutics Reports First Quarter 2023 Financial Results; Provides Corporate Update

May 10, 2023

Rani Therapeutics to Participate in the H.C. Wainwright BioConnect Investor Conference at NASDAQ

Apr 25, 2023

Rani Therapeutics to Present at the 22nd Annual Needham Virtual Healthcare Conference

Apr 11, 2023

Rani Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results; Provides Corporate Update

Mar 22, 2023

Rani Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results and Business Updates

Mar 16, 2023

Celltrion and Rani Therapeutics Partner on Development of Oral Monoclonal Antibody Treatment

Jan 09, 2023

Rani Therapeutics Receives Feedback from Pre-IND Meeting with FDA; Provides Pipeline Update

Jan 05, 2023

Print Page
Email Alerts
RSS Feeds
Contact IR

Company

About
Careers
Contact

Resources

News
Applications
Technology

San Jose Office

2051 Ringwood Ave. San Jose CA, 95131

© Rani Therapeutics. All Rights Reserved. Rani, Rani Therapeutics, and RaniPill and their corresponding logos are trademarks or registered trademarks of Rani Therapeutics, LLC in the US and other countries.